Aldaya, Nicole .
HRN: 28-36-22 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2026
CEFUROXIME 500MG (TAB)
01/02/2026
01/09/2026
PO
1 Tab
BID
S/P NSVD
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes